查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1318973

疫苗合約製造市場：按功能、類型和用途分類－2023年至2030年全球預測

Vaccine Contract Manufacturing Market by Function, Type, Applications - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球疫苗合約製造市場將大幅成長至302,049萬美元，複合年成長率為12.91%，2030年將達707654萬美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球疫苗合約製造市場至關重要。透過檢驗業務策略和產品滿意度等關鍵指標，它可以對供應商進行全面評估，使用戶能夠根據自己的特定需求做出資訊的決策。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對整體收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解自家公司在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球疫苗合約生產市場規模及預測是多少？

2.在預測期內，COVID-19對全球疫苗合約製造市場的阻礙因素和影響為何？

3. 在預測期內，全球疫苗合約製造市場需要投資哪些產品/細分市場/用途/領域？

4.你們在全球疫苗合約生產市場的競爭策略是什麼？

5.全球疫苗合約生產市場的技術趨勢和法律規範是什麼？

6.全球疫苗合約生產市場主要供應商的市佔率是多少？

7. 哪些型態和策略措施被認為適合進入全球疫苗合約製造市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 疫苗需求增加將導致合約製造商擴大產能
      • 主要優勢包括透過合約服務節省成本和時間
      • 全球均可接種疫苗
    • 抑制因素
      • 由一家歷史悠久的疫苗製造商進行有限的外包
    • 機會
      • 全球需求不斷成長，以滿足不斷成長的不同年齡層人口的需求
      • 創新和強大的疫苗管道
      • 政府對加速疫苗生產的有利見解和指導方針
    • 任務
      • 製藥公司開展自家公司的生產業務並進行策略管理
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化
    • 與 COVID-19 相關的供應鏈趨勢
    • 自動化疫苗開發
    • 生物加工企業合作形勢

第6章 疫苗合約製造市場：依功能分類

  • 介紹
  • 下游
    • 分析和品質控制研究
    • 填充和整理操作
    • 包裝
  • 上游
    • 細菌表現系統
    • 桿狀病毒或昆蟲表現系統
    • 哺乳動物表達系統
    • 酵母表現系統

第7章 疫苗合約製造市場：按類型

  • 介紹
  • 減毒疫苗
  • DNA疫苗
  • 去活化疫苗
  • 亞單位疫苗
  • 類毒素疫苗

第8章 疫苗合約製造市場：依用途

  • 介紹
  • 人類使用
  • 動物醫學

第9章 美洲疫苗合約製造市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太疫苗合約製造市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲疫苗合約製造市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-430D42AA0DCE

The Global Vaccine Contract Manufacturing Market is forecasted to grow significantly, with a projected USD 3,020.49 million in 2023 at a CAGR of 12.91% and expected to reach a staggering USD 7,076.54 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Vaccine Contract Manufacturing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Vaccine Contract Manufacturing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Function, market is studied across Downstream and Upstream. The Downstream is further studied across Analytical & QC studies, Fill & Finish Operations, and Packaging. The Upstream is further studied across Bacterial Expression Systems, Baculovirus or Insect Expression Systems, Mammalian Expression Systems, and Yeast Expression Systems. The Downstream is projected to witness significant market share during forecast period.

Based on Type, market is studied across Attenuated Vaccine, DNA Vaccines, Inactivated Vaccine, Subunit Vaccines, and Toxoid Vaccines. The DNA Vaccines is projected to witness significant market share during forecast period.

Based on Applications, market is studied across Human Use and Veterinary. The Human Use is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Vaccine Contract Manufacturing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Vaccine Contract Manufacturing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vaccine Contract Manufacturing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vaccine Contract Manufacturing Market?

4. What is the competitive strategic window for opportunities in the Global Vaccine Contract Manufacturing Market?

5. What are the technology trends and regulatory frameworks in the Global Vaccine Contract Manufacturing Market?

6. What is the market share of the leading vendors in the Global Vaccine Contract Manufacturing Market?

7. What modes and strategic moves are considered suitable for entering the Global Vaccine Contract Manufacturing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Vaccine Contract Manufacturing Market, by Function, 2022 vs 2030
  • 4.3. Vaccine Contract Manufacturing Market, by Type, 2022 vs 2030
  • 4.4. Vaccine Contract Manufacturing Market, by Applications, 2022 vs 2030
  • 4.5. Vaccine Contract Manufacturing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for vaccines leading to capacity expansion by contract manufacturers
      • 5.1.1.2. Key advantages such as cost and time saving offered by contract services
      • 5.1.1.3. Vaccination coverage across the globe
    • 5.1.2. Restraints
      • 5.1.2.1. Limited outsourcing by well-established vaccine manufacturers
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising global demand to cater to the growing population of varied age groups
      • 5.1.3.2. Innovation and robust vaccine pipeline
      • 5.1.3.3. Favorable government insights and guidelines to speed up the vaccine manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Pharma companies manufacturing operations in-house to gain strategic control
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization
    • 5.9.1. Supply Chain Trend Associated with COVID-19
    • 5.9.2. Automation in Vaccine Development
    • 5.9.3. Collaborative Landscape among Bioprocessing Companies

6. Vaccine Contract Manufacturing Market, by Function

  • 6.1. Introduction
  • 6.2. Downstream
    • 6.2.1. Analytical & QC studies
    • 6.2.2. Fill & Finish Operations
    • 6.2.3. Packaging
  • 6.3. Upstream
    • 6.3.1. Bacterial Expression Systems
    • 6.3.2. Baculovirus or Insect Expression Systems
    • 6.3.3. Mammalian Expression Systems
    • 6.3.4. Yeast Expression Systems

7. Vaccine Contract Manufacturing Market, by Type

  • 7.1. Introduction
  • 7.2. Attenuated Vaccine
  • 7.3. DNA Vaccines
  • 7.4. Inactivated Vaccine
  • 7.5. Subunit Vaccines
  • 7.6. Toxoid Vaccines

8. Vaccine Contract Manufacturing Market, by Applications

  • 8.1. Introduction
  • 8.2. Human Use
  • 8.3. Veterinary

9. Americas Vaccine Contract Manufacturing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Vaccine Contract Manufacturing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Vaccine Contract Manufacturing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. VACCINE CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2022 VS 2030 (%)
  • FIGURE 5. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 6. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2022 VS 2030 (%)
  • FIGURE 7. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. VACCINE CONTRACT MANUFACTURING MARKET DYNAMICS
  • FIGURE 9. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. VACCINE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. VACCINE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. VACCINE CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 5. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 6. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QC STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 11. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACULOVIRUS OR INSECT EXPRESSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN EXPRESSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ATTENUATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 23. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY HUMAN USE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY VETERINARY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 234. VACCINE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 235. VACCINE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 236. VACCINE CONTRACT MANUFACTURING MARKET LICENSE & PRICING